2023 BIO One-on-One Partnering @ JPM Week; January 9-12 | ASC

BIO Partnering at JPM 2023 | ASC

Meet our team at the 2023 BIO One-on-One Partnering event at JPM week. Schedule your meeting with Applied StemCell’s experts today!

When: January 9-12, 2023

Where: San Francisco, CA

Register:  https://www.bio.org/events/bio-partnering-jpm/registration

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 13 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATTTM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
maki.ogawa@appliedstemcell.com

Google